Skip to content

CRISPR Therapeutics

US · CRSP #2057 by market cap Listed 2016
39.10 +0.17 +0.44%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:54

Quant vs Street three independent views, side by side

StockVane factor grade
D
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Morgan Stanley moved from Sell to Hold on 2026-08-04.

Analyst consensus 12 analysts

Buy
Avg price target 74.27 +89.9%
Price target rangecurrent 39.10
Low50.00
Avg74.27
High110.00
Buy 67% Hold 33% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 Needham -- Buy 82.00
2026-11-10 H.C. Wainwright -- Buy 80.00
2026-11-09 UBS -- Hold 52.00
2026-11-09 Piper Sandler -- Buy 110.00
2026-11-09 Needham -- Buy 82.00
2026-11-09 H.C. Wainwright -- Buy 80.00
2026-11-09 J.P. Morgan -- Buy 67.00
2026-11-08 Citi -- Buy 90.00
2026-11-04 Wells Fargo -- Hold 70.00
2026-11-04 BofA Securities -- Buy 80.00
2026-11-04 Citi -- Buy 90.00
2026-11-04 H.C. Wainwright -- Buy 80.00
2026-11-03 Wells Fargo -- Hold 70.00
2026-11-03 UBS -- Hold 52.00
2026-11-03 Piper Sandler -- Buy 110.00
2026-11-03 H.C. Wainwright -- Buy 80.00
2026-11-03 RBC Capital -- Hold 50.00
2026-11-03 J.P. Morgan -- Buy --
2026-10-15 UBS -- Hold 52.00
2026-10-14 UBS -- Hold 52.00
2026-10-09 BofA Securities -- Buy 81.00
2026-10-09 H.C. Wainwright -- Buy 80.00
2026-10-05 Needham -- Buy 82.00
2026-10-02 Wells Fargo -- Hold 75.00
2026-09-04 Citi -- Buy 88.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-08-04 Morgan Stanley Sell → Hold 60.00

Quote time 2026-11-20 19:54:43 · For reference only, not investment advice and not tailored to your situation.

CRISPR Therapeutics discussion 0 comments

Add a comment